STOCK TITAN

If You Invested in Essilorluxottica (ESLOY)

Healthcare · Medical Instruments & Supplies · OTC Link
Looking for the live price? See the ESLOY quote & overview
$1,000 invested 1 Year Ago
$655
-34.5% total -34.6% CAGR
Bought on Jul 9, 2025 at $148.68
$1,000 invested 5 Years Ago
$1,064
+6.4% total 1.3% CAGR
Bought on Jul 9, 2021 at $91.50

What $1,000 or $10,000 in ESLOY Would Be Worth Today

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Jul 10, 2015
$1,000 $655 -35% $1,064 +6% $1,453 +45% $1,550 +55%
$10,000 $6,549 -35% $10,642 +6% $14,533 +45% $15,502 +55%

Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for ESLOY

$1,000 Investment Over Time

ESLOY vs S&P 500

Year-by-Year Returns

ESLOY annual performance
Year Start Price End Price Annual Return Cumulative
2017 $55.46 $68.98 +24.4% +24.4%
2018 $68.16 $63.16 -7.3% +13.9%
2019 $62.93 $76.59 +21.7% +38.1%
2020 $76.66 $77.76 +1.4% +40.2%
2021 $78.71 $106.91 +35.8% +92.8%
2022 $106.18 $90.58 -14.7% +63.3%
2023 $90.04 $100.49 +11.6% +81.2%
2024 $99.18 $120.67 +21.7% +117.6%
2025 $119.90 $158.42 +32.1% +185.6%
2026 $155.90 $97.37 -37.5% +75.6%

About Essilorluxottica

Healthcare · OTC Link

ESSILOR LXTTCA UNSP/ADR (ESLOY) represents interests in EssilorLuxottica, a global company in the healthcare sector with a focus on medical instruments and supplies related to vision care and eyewear. According to company disclosures, EssilorLuxottica is engaged in the design, manufacture and distribution of advanced vision care products, eyewear and med‑tech solutions, combining lens technologies, eyewear brands and retail networks under one group.

EssilorLuxottica describes its mission as helping people around the world to see more and be more by addressing evolving vision needs, personal style aspirations and the desire to feel more connected to the world. The group highlights its role in vision care and eyewear through a portfolio that spans lens technologies, iconic eyewear brands and retail chains.

Business focus and activities

Based on the company’s own description, EssilorLuxottica is involved in:

  • Advanced vision care products, including lens technologies such as Varilux, Stellest and Transitions.
  • Eyewear design and manufacturing, with brands such as Ray‑Ban, Oakley and Supreme, as well as licensed luxury brands.
  • Retail distribution of eyewear and vision products through banners including Sunglass Hut, LensCrafters, Vision Express, Apollo and other optical and sunglass retailers.
  • Med‑tech solutions for eye health and category‑defining smart glasses, as described by the company.

The company states that it invests in research and development and maintains capabilities and assets that support innovation across categories, from medical instruments and solutions for eye health to smart glasses products.

Global footprint and scale

EssilorLuxottica reports that it has employees across numerous countries, operates many facilities and stores, and generates consolidated revenue in the tens of billions of euros. The group’s shares trade on the Euronext Paris market and are included in the Euro Stoxx 50 and CAC 40 indices, under codes and symbols including ISIN FR0000121667, Reuters ESLX.PA and Bloomberg EL:FP.

Through its OneSight EssilorLuxottica Foundation, the company reports that it has provided access to sustainable vision care to a large number of people in underserved communities. This philanthropic activity is presented as part of its broader commitment to vision care access.

Nuance Audio Glasses and med‑tech positioning

EssilorLuxottica has announced Nuance Audio Glasses, described as an invisible open‑ear hearing solution integrated into eyewear for adults with perceived mild to moderate hearing loss. These smart glasses are presented as FDA‑registered over‑the‑counter hearing aids in the United States, combining sound engineering with eyewear design.

According to the company, Nuance Audio Glasses integrate directional microphones and open‑ear speakers, using beamforming technology to focus on important sounds while reducing background noise. The product is designed as an all‑in‑one solution that addresses both vision and hearing needs in a single frame, with customization options for prescription optical lenses and Transitions lenses for adaptive light control.

The Nuance Audio App is described as the companion application required for setup, audio calibration and firmware updates of Nuance Audio Glasses. The app allows users to manage noise reduction levels, switch between audio modes, choose from preset amplification settings and adjust volume. Certain settings can also be adjusted directly from the glasses.

Retail and consumer engagement

EssilorLuxottica’s retail presence includes Sunglass Hut, which the company describes as a curated destination for fashion and performance sunglass brands. Sunglass Hut operates thousands of retail locations in shopping districts across multiple regions, offering an in‑store and online shopping experience.

Sunglass Hut has introduced The Sun Club, a loyalty program designed to reward customers with points for purchases and engagement activities. Members can progress through multiple tiers and receive benefits such as promotions, gifts with purchase, access to exclusive product launches and other perks. This program illustrates how EssilorLuxottica’s retail banners seek to build ongoing relationships with eyewear consumers.

Brand and technology portfolio

EssilorLuxottica highlights a portfolio that includes:

  • Lens technologies: Varilux, Stellest and Transitions, which the company identifies as innovative lens brands.
  • Eyewear brands: Ray‑Ban, Oakley and Supreme, along with licensed luxury brands.
  • Retail banners: Sunglass Hut, LensCrafters, Vision Express, Apollo and others.
  • Smart glasses and med‑tech products: including category‑defining smart glasses and Nuance Audio Glasses.

Through these activities, EssilorLuxottica positions itself as a group that connects lens technology, eyewear design, med‑tech solutions and retail distribution in a single organization.

Stock and investor context

ESSILOR LXTTCA UNSP/ADR (ESLOY) provides a way for investors to access interests in EssilorLuxottica through an unsponsored American depositary receipt structure. While ESLOY itself does not file separate SEC reports in the data provided, the underlying company reports its financial and operational information through its primary listing on Euronext Paris and related disclosures.

Investors researching ESLOY often focus on EssilorLuxottica’s role in vision care, eyewear brands, med‑tech developments such as Nuance Audio Glasses, and its global retail and manufacturing footprint, as described in company communications.

Market Cap
$102.6B
Current Price
$97.37
View full ESLOY overview

Frequently Asked Questions

Essilorluxottica investment returns

How much would $1,000 invested in Essilorluxottica be worth today?

If you invested $1,000 in Essilorluxottica (ESLOY) 10 years ago on 2016-07-11, your investment would be worth $1,453 today, representing a +45.3% total return, growing at a compounded rate of 3.8% per year (CAGR).

Has Essilorluxottica outperformed the S&P 500?

Over the past 10 years, ESLOY returned +45.3% compared to +249.3% for the S&P 500, underperforming the benchmark by 204.0 percentage points.

What is Essilorluxottica's average annual return?

The compound annual growth rate (CAGR) of ESLOY over the past 10 years is 3.8%, growing at a compounded rate each year. Individual years vary significantly — ESLOY's best recent year was 2021 (+35.8%) and worst was 2026 (-37.5%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.